CoChat

RNA-Targeting CRISPR-Cas systems and their applications

Open access
Burmistrz, Michal, Krakowski, Kamil, Krawczyk-Balska, Agata · 2020 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.

Abstract

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)–CRISPR-associated (Cas) systems have revolutionized modern molecular biology. Numerous types of these systems have been discovered to date. Many CRISPR–Cas systems have been used as a backbone for the development of potent research tools, with Cas9 being the most widespread. While most of the utilized systems are DNA-targeting, recently more and more attention is being gained by those that target RNA. Their ability to specifically recognize a given RNA sequence in an easily programmable way makes them ideal candidates for developing new research tools. In this review we summarize current knowledge on CRISPR–Cas systems which have been shown to target RNA molecules, that is type III (Csm/Cmr), type VI (Cas13), and type II (Cas9). We also present a list of available technologies based on these systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms21031122

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Mechanism of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)–CRISPR-associated (Cas) type III (Csm/Cmr) system. Cas6 endoribonuclease cleaves pre-CRISPR RNA (pre-crRNA) within the repeat region. Subsequently, the ribonucleoprotein (RNP) complex is assembled, while the 3′ end of crRNA is trimmed by an unknown nuclease. There are three nuclease activities of the RNP complex: (a) specific RNA cleavage, (b) non-specific ssDNA cleavage, (c) non-specific RNA degradation (details in the main text).
Figure 1 Mechanism of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)–CRISPR-associated (Cas) type III (Csm/Cmr) system. Cas6 endoribonuclease cleaves pre-CRISPR RNA (pre-crRNA) within the repeat region. Subsequently, the ribonucleoprotein (RNP) complex is assembled, while the 3′ end of crRNA is trimmed by an unknown nuclease. There are three nuclease activities of the RNP complex: (a) specific RNA cleavage, (b) non-specific ssDNA cleavage, (c) non-specific RNA degradation (details in the main text).CC BY · PubMed Central
Figure 2 Mechanism of the CRISPR–Cas13 (type VI) system. The CRISPR array is transcribed into a long pre-crRNA transcript, which is subsequently processed into mature crRNAs by Cas13 protein. The crRNA-Cas13 complex scans the ssRNA searching for protospacer. Complementarity between crRNA and the protospacer sequence together with the presence of Protospacer Flanking Sequence (PFS) (green circle) induces conformational changes of Cas13, which results in higher eukaryotes and prokaryotes nucleotide binding (HEPN) domains activation and their displacement to the protein surface. This results in nonspecific RNA cleavage.
Figure 2 Mechanism of the CRISPR–Cas13 (type VI) system. The CRISPR array is transcribed into a long pre-crRNA transcript, which is subsequently processed into mature crRNAs by Cas13 protein. The crRNA-Cas13 complex scans the ssRNA searching for protospacer. Complementarity between crRNA and the protospacer sequence together with the presence of Protospacer Flanking Sequence (PFS) (green circle) induces conformational changes of Cas13, which results in higher eukaryotes and prokaryotes nucleotide binding (HEPN) domains activation and their displacement to the protein surface. This results in nonspecific RNA cleavage.CC BY · PubMed Central
Figure 3 Mechanism of the CRISPR–Cas9 (type II) system. (a) DNA targeting CRISPR array transcription generates pre-crRNA. Maturation of the crRNAs is dependent on trans activating RNA (tracrRNA), which is partially complementary to the repeat sequences in the pre-crRNA resulting in tracrRNA/crRNA duplex formation. Those duplexes are bound and stabilized by Cas9 protein. Host RNase III is then recruited to cleave pre-crRNA into units containing single spacer sequences. Further trimming of the crRNAs is performed by unknown ribonuclease. The complex of Cas9 and single guide RNA (sgRNA: tracrRNA–crRNA) scans DNA until it finds a Protospacer-Associated Motif (PAM) sequence. The DNA strand is then unwound, allowing sgRNA for complementarity verification. Positive recognition results in cleavage of both DNA strands. (b) scaRNA-dependent RNA targeting was observed for Cas9 from Francisella novicida (FnCas9). Small CRISPR/Cas-associated RNA (scaRNA) hybridizes with tracrRNA to form heteroduplex that binds Cas9 protein. FnCas9–tracrRNA/scaRNA complex targets RNA partially complementary to scaRNA sequence. The precise mechanism of FnCas9 remains unclear. (c) PAM-presenting oligonucleotide (PAMer)-dependent RNA targeting Functional Cas9–sgRNA complex is able to target RNA in the presence of PAMmers–short DNA oligonucleotides containing PAM. When the PAMmer is bound to target RNA, the Cas9–sgRNA complex is able to recognize and cleave the RNA as long as complementarity between sgRNA and targeted RNA is maintained.
Figure 3 Mechanism of the CRISPR–Cas9 (type II) system. (a) DNA targeting CRISPR array transcription generates pre-crRNA. Maturation of the crRNAs is dependent on trans activating RNA (tracrRNA), which is partially complementary to the repeat sequences in the pre-crRNA resulting in tracrRNA/crRNA duplex formation. Those duplexes are bound and stabilized by Cas9 protein. Host RNase III is then recruited to cleave pre-crRNA into units containing single spacer sequences. Further trimming of the crRNAs is performed by unknown ribonuclease. The complex of Cas9 and single guide RNA (sgRNA: tracrRNA–crRNA) scans DNA until it finds a Protospacer-Associated Motif (PAM) sequence. The DNA strand is then unwound, allowing sgRNA for complementarity verification. Positive recognition results in cleavage of both DNA strands. (b) scaRNA-dependent RNA targeting was observed for Cas9 from Francisella novicida (FnCas9). Small CRISPR/Cas-associated RNA (scaRNA) hybridizes with tracrRNA to form heteroduplex that binds Cas9 protein. FnCas9–tracrRNA/scaRNA complex targets RNA partially complementary to scaRNA sequence. The precise mechanism of FnCas9 remains unclear. (c) PAM-presenting oligonucleotide (PAMer)-dependent RNA targeting Functional Cas9–sgRNA complex is able to target RNA in the presence of PAMmers–short DNA oligonucleotides containing PAM. When the PAMmer is bound to target RNA, the Cas9–sgRNA complex is able to recognize and cleave the RNA as long as complementarity between sgRNA and targeted RNA is maintained.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Cited by

See all 131

Metadata

Authors
Burmistrz, M., Krakowski, K., & Krawczyk-Balska, A.
Affiliations
  • Department of Molecular Microbiology, Biological and Chemical Research Centre, Faculty of Biology, University of Warsaw, 02-089 Warsaw, Poland
  • University of Warsaw (PL)
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-02-07
Volume
21
Issue
3
Pages
1122
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3004935084
Cited by
125
References
81
Citations by year
2026: 11 · 2025: 13 · 2024: 18 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 8
FWCI
1.99
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Center of Science, Poland (2016/21/B/NZ6/00963)
  • Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw (intramural grant DSM no. 501-D114-01-1140400)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
CRISPR/Cas9, Cas13, type III CRISPR-Cas, RNA interference, RNA cleavage, genome editing tools
MeSH terms
Gene Editing, Animals, Humans, CRISPR-Cas Systems, CRISPR-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RNA-Targeting CRISPR-Cas systems and their applications. https://app.cochat.ai/papers/10.3390/ijms21031122
The paper
Burmistrz, M., Krakowski, K., & Krawczyk-Balska, A. (2020). RNA-Targeting CRISPR-Cas systems and their applications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21031122

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.